Delivery Order SPE2DB24D9134-SPE2DB24FZCQ0

Award Date 9/12/24
Potential Completion Date 10/3/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,094.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of YF-VAX 1 DOSE VIALS, a pharmaceutical product, with a completion date of September 18, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 26, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,634.90 delivery order is for the supply of YF-VAX 1 dose vials and has a firm fixed-price pricing structure with an ultimate completion date of October 21, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,634.90 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with an ultimate completion date of October 31, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,670.13 firm fixed-price delivery order contract is for the provision of YF-VAX 1 dose vials, which are specialized pharmaceutical products. The contract has an ultimate completion date of February 14, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,134.20 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials and has a completion date of February 27, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials (4566199030). The contract has an ultimate completion date of November 14, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,323.00 firm fixed-price delivery order under contract SPE2DB22FL0H1 is for the supply of YF-VAX 1 dose vials and has an ultimate completion date of January 12, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $34,584.00 delivery order for YF-VAX 1 dose vials, with a firm fixed-price pricing type and an ultimate completion date of September 16, 2021. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,198.39 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with an ultimate completion date of October 15, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which runs through December...
  • SPE2DB24D9134
    Indefinite Delivery Contract
  • SPE2DB24D9134-SPE2DB24FZCQ0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.47 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a completion date of October 3, 2024.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of Department of Defense healthcare facilities worldwide. This delivery order is part of that larger IDC vehicle, further solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain. The contract does not have a set-aside designation.

Generated 12/12/24, 10:03 AM